Ultrasmall iron oxide nanoparticles have recently attracted much attention as T1 (positive)
contrast agents for magnetic resonance imaging to serve as safer alternatives to gadolinium …

The disadvantages that come with traditional cancer treatments, such as chemotherapy and
radiotherapy, generated a research shift toward nanotechnology. However, even with the …

Hepatic cancer is a serious disease with high morbidity and mortality. Theranostic agents
with effective diagnostic and therapeutic capability are highly needed for the treatment of …

Iron oxide nanoparticles have been extensively utilised as negative (T 2) contrast agents in
magnetic resonance imaging. In the past few years, researchers have also exploited their …

Metal complexes are of increasing interest as pharmaceutical agents in cancer diagnostics
and therapeutics, while some of them suffer from issues such as limited water solubility and …

Timely diagnosis and appropriate antitumoral treatments remain of utmost importance, since
cancer remains a leading cause of death worldwide. Within this context, nanotechnology …

Cancer is one of the most deadly diseases in the world. In recent years, nanotechnology, as
a unique technology, has been comprehensively applied in the therapy of cancer through …

Molecular imaging continues to influence every aspect of cancer care including detection,
diagnosis, staging and therapy response assessment. Recent advances in the …

The conventional chemotherapeutics could not be traced in vivo and provide timely
feedback on the clinical effectiveness of drugs. Methods: In this study, a tumor-penetrating …

Nanomedicine in oncology has not had the success in clinical impact that was anticipated in
the early stages of the field's development. Ideally, nanomedicines selectively accumulate in …